Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Nilsson

Showing results (141-150 of 182) with videos related to

Pageof 19
Sort By:
Breast Cancer Research and Treatment|August 21, 2002
Indium-111-octreotide scintigraphy, intraoperative gamma-detector localisation and somatostatin receptor expression in primary human breast cancerJan Skånberg, Håkan Ahlman, Sven-Anders Benjegård, et al.
Plos Genetics|June 9, 2020
MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progressionTajana Tešan Tomić, Josefin Olausson, Anna Rehammar, et al.
Journal of the Endocrine Society|December 22, 2017
Aggrecan Mutations in Nonfamilial Short Stature and Short Stature Without Accelerated Skeletal MaturationChristina Tatsi, Alexandra Gkourogianni, Klaus Mohnike, et al.
The Journal of Clinical Endocrinology and Metabolism|April 26, 2014
Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutationsOla Nilsson, Michael H Guo, Nancy Dunbar, et al.
EJNMMI Research|March 22, 2019
Transcriptional effects of <sup>177</sup>Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude miceJohan Spetz, Britta Langen, Nils-Petter Rudqvist, et al.
Scientific Reports|July 18, 2023
Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paragangliomaSinan Karakaya, Lisa Gunnesson, Erik Elias, et al.
Orphanet Journal of Rare Diseases|February 28, 2019
FGF23 and its role in X-linked hypophosphatemia-related morbiditySigne Sparre Beck-Nielsen, Zulf Mughal, Dieter Haffner, et al.
Endocrine-Related Cancer|November 17, 2012
Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutationNimrod B Kiss, Andreas Muth, Adam Andreasson, et al.
Frontiers in Endocrinology|February 17, 2023
Burosumab for X-linked hypophosphatemia in children and adolescents: Opinion based on early experience in seven European countriesM Zulf Mughal, Giampiero I Baroncelli, Carmen de Lucas-Collantes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2021
Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus VaccinationJohn Tyler Sandberg, Sebastian Ols, Marie Löfling, et al.
Pageof 19

Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
Breast Cancer Research and Treatment|August 21, 2002
Indium-111-octreotide scintigraphy, intraoperative gamma-detector localisation and somatostatin receptor expression in primary human breast cancerJan Skånberg, Håkan Ahlman, Sven-Anders Benjegård, et al.
Plos Genetics|June 9, 2020
MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progressionTajana Tešan Tomić, Josefin Olausson, Anna Rehammar, et al.
Journal of the Endocrine Society|December 22, 2017
Aggrecan Mutations in Nonfamilial Short Stature and Short Stature Without Accelerated Skeletal MaturationChristina Tatsi, Alexandra Gkourogianni, Klaus Mohnike, et al.
The Journal of Clinical Endocrinology and Metabolism|April 26, 2014
Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutationsOla Nilsson, Michael H Guo, Nancy Dunbar, et al.
EJNMMI Research|March 22, 2019
Transcriptional effects of <sup>177</sup>Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude miceJohan Spetz, Britta Langen, Nils-Petter Rudqvist, et al.
Scientific Reports|July 18, 2023
Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paragangliomaSinan Karakaya, Lisa Gunnesson, Erik Elias, et al.
Orphanet Journal of Rare Diseases|February 28, 2019
FGF23 and its role in X-linked hypophosphatemia-related morbiditySigne Sparre Beck-Nielsen, Zulf Mughal, Dieter Haffner, et al.
Endocrine-Related Cancer|November 17, 2012
Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutationNimrod B Kiss, Andreas Muth, Adam Andreasson, et al.
Frontiers in Endocrinology|February 17, 2023
Burosumab for X-linked hypophosphatemia in children and adolescents: Opinion based on early experience in seven European countriesM Zulf Mughal, Giampiero I Baroncelli, Carmen de Lucas-Collantes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2021
Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus VaccinationJohn Tyler Sandberg, Sebastian Ols, Marie Löfling, et al.
Pageof 19